Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Azitra Inc Common Stock
(NY:
AZTR
)
0.4167
+0.0187 (+4.70%)
Official Closing Price
Updated: 8:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Azitra Inc Common Stock
< Previous
1
2
3
4
Next >
On Thursday, there are stocks with unusual volume. Let's take a look.
February 06, 2025
Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 05, 2025
Via
Benzinga
Tuesday's session: most active stocks
February 04, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
Via
Chartmill
Tuesday's session: top gainers and losers
February 04, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via
Chartmill
AZTR Stock Earnings: Anitra Reported Results for Q2 2024
August 12, 2024
Anitra just reported results for the second quarter of 2024.
Via
InvestorPlace
Traders are paying attention to the gapping stocks in Tuesday's session.
February 04, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
US Stocks Mixed; PepsiCo Posts Downbeat Sales
February 04, 2025
Via
Benzinga
Discover the top movers in Tuesday's pre-market session.
February 04, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 04, 2025
Via
Benzinga
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
February 04, 2025
Via
Benzinga
Friday's after hours session: top gainers and losers
January 24, 2025
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 23, 2025
Via
Benzinga
Crude Oil Rises Sharply; JPMorgan Chase Earnings Top Views
January 15, 2025
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Surges Over 2%; Goldman Sachs Posts Upbeat Q4 Results
January 15, 2025
Via
Benzinga
Dow Jumps 600 Points; US Inflation Increases To 2.9% In December
January 15, 2025
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 15, 2025
Via
Benzinga
Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket
January 15, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 14, 2025
Via
Benzinga
Azitra to Present at BIO-Europe 2024
October 29, 2024
From
Azitra, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
October 11, 2024
From
Azitra, Inc.
Via
Business Wire
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
October 04, 2024
Via
Benzinga
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
September 24, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
September 18, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 06, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 28, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
August 22, 2024
From
Azitra, Inc.
Via
Business Wire
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 20, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
August 12, 2024
From
Azitra, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.